Clinical trials
Observational Acute Kidney Injury trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
161 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 3 |
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 3 |
| 2013 | 7 |
| 2014 | 4 |
| 2015 | 5 |
| 2016 | 4 |
| 2017 | 11 |
| 2018 | 11 |
| 2019 | 13 |
| 2020 | 17 |
| 2021 | 16 |
| 2022 | 19 |
| 2023 | 21 |
| 2024 | 20 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 161 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Assiut University | 13 |
| National Taiwan University Hospital | 8 |
| Heinrich-Heine University, Duesseldorf | 4 |
| Inonu University | 4 |
| Sohag University | 4 |
| Guy's and St Thomas' NHS Foundation Trust | 3 |
| University Hospital, Strasbourg, France | 3 |
| Uppsala University | 3 |
| Yonsei University | 3 |
| Ankara City Hospital Bilkent | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Acute Kidney Injury | 161 |
| Sepsis | 14 |
| Critical Illness | 10 |
| Renal Insufficiency | 6 |
| Shock, Septic | 6 |
| Shock | 5 |
| Heart Failure | 4 |
| Kidney Diseases | 4 |
| Respiratory Distress Syndrome | 4 |
| Acute-On-Chronic Liver Failure | 3 |
Trials
Showing 1 to 25 of 161. Each trial links to its page on Pharma Observatory.
61 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.